Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide for Post-Transplant Diabetes Mellitus
NCT01165944Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Aug 2009
- Primary completion
- Aug 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pramlintide in post-transplant diabetes mellitus (PTDM), sponsored by University of Colorado Denver. Planned start Aug 2009; status: withdrawn.
02
Drugs
pramlintide
03
Conditions
post-transplant diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT01165944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165944.